Purposes: Incomplete tendon healing impairs the outcome of tendon ruptures and tendinopathies. 23 Human Adipose-derived Stem Cells (hASCs) are promising for tissue engineering applications. 24 Extracorporeal Shock Waves (ESW) are a leading choice for the treatment of several 25 tendinopathies. In this study we investigated the effects of ESW treatment and tenogenic medium 26 on the differentiation of hASCs into tenoblast-like cells. Materials and Methods: hASCs were 27 treated with ESW generated by a piezoelectric device and tenogenic medium. Quantitative real-time 28 PCR was used to check mRNA expression levels of tenogenic transcription factors, extracellular 29 matrix proteins, and integrins. Western blot and immunofluorescence were used to detect collagen 1 30 and fibronectin. Collagen fibers were evaluated by Masson staining. Calcium deposition was 31 assessed by Alizarin Red staining. Results: The combined treatment improved the expression of the 32 tendon transcription factors scleraxis and eyes absent 2, and of the extracellular matrix proteins 33 fibronectin, collagen I, and tenomodulin. Cells acquired elongated and spindle shaped fibroblastic 34 morphology; Masson staining revealed the appearance of collagen fibers. Finally, the combined 35 treatment induced the expression of alpha 2, alpha 6 and beta 1 integrin subunits, suggesting a 36 possible role in mediating ESW effects. Conclusions: ESW in combination with tenogenic medium 37 improved the differentiation of hASCs towards tenoblast-like cells, providing the basis for ESW 38 and hASCs to be used in tendon tissue engineering.
Introduction
polymerase chain reaction was performed using a BioRad iQ iCycler Detection System (Bio-Rad 150 Laboratories S.r.l., Milan, Italy) with SYBR green fluorophore. Reactions were performed in a total 151 volume of 25 μl containing 12.5 μl IQ SYBR Green Supermix (Bio-Rad Laboratories S.r.l., Milan, 152 Italy), 1 μl of each primer at 10 μM concentration, and 5 μl of the previously reverse-transcribed 153 cDNA template. The protocol used is as follows: denaturation (95°C for 5 min), amplification 154 repeated 40 times (95°C for 15 s, 60°C for 30 s). A melting curve analysis was performed following 155 every run to ensure a single amplified product for every reaction. All reactions were carried out at 156 least in triplicate for each sample. Results were normalized using the geometric mean for three 157 different housekeeping genes (β-actin and ribosomal protein L13A and RPLPO) and expressed as 158 relative expression fold vs untreated controls (Basal).
159
Immunofluorescence microscopy 160 After different treatments, cells (2×10 3 ) were seeded in 96-well plates (Corning, New York, NY, 161 USA). After 1 and 4 weeks, cells were fixed in acetone/methanol (1:1) at 4°C for 20 minutes, 162 permeabilized with PBS containing 0.5% Triton X-100, 0.05% NaN 3 and incubated with the 163 following antibodies: polyclonal sheep anti-type I collagen (COL1, 2 g/ml, R&D Systems, 164 Minneapolis, MN, USA) and polyclonal rabbit anti-fibronectin 1 (FN1, 1:500, Sigma-Aldrich, 165 Saint Louis, MO 190 After different treatments, cells (25x10 4 ) were seeded on sterilized coverslips (22 x 22 mm) placed 191 in 6 cm Petri dishes and kept in a humidified incubator with 5% CO 2 at 37°C.
192
After 4 weeks, the cells grown on coverslips were fixed in 4% neutral-buffered formalin for 10 min Slides were observed by microscope Leica DM2000 (Leica Microsystems, Wetzlar, Germany) and 201 photos were taken by Leica ICC50 HD digital camera system (Leica Microsystems, Wetzlar,
Results

219
hASC characterization 220 More than 95% of hASCs expressed CD13, CD44 and CD105, whereas a very low expression of 221 CD14 (1%) and no expression of CD34 and CD45 was detected (Table S2 ). Moreover, a positivity 222 of at least 95% for the same markers was also maintained in subsequent steps (data not shown). As 223 we reported elsewhere (14,15), hASCs were able to differentiate into osteogenic and adipogenic 224 lineages under specific culture conditions, confirming their differentiating potential. 226 The energy level and number of shots used for ESW treatment (EFD =0.32 mJ/mm 2 ; peak positive 227 pressure 90 MPa, 1000 shots) allowed a viability > 80% soon after treatment (Table S2) 255 The effect on the extracellular matrix proteins FN1 and COL1 was further confirmed by the 256 evaluation of protein deposition.
225
ESW effect on cell viability and morphology
Effects on extracellular matrix protein deposition
257
Effects on FN1 258
After 7-day-treatments, tenogenic medium significantly increased FN1 production, as demonstrated 
264
Effects on COL1 265 The same behavior was also observed for COL1 production. In fact, after 7 days, already tenogenic 266 medium alone significantly increased COL1 (immunofluorescence, Figure 4 280 To get insights into the mechanisms involved in the effect of ESW in tenogenic differentiation, the 281 expression of integrins involved in mechanotransduction was assessed. We evaluated the expression 
279
Effects on integrin expression
289
The expression of G Figure 6, 
293
The expression of G 1 Figure 6, 298 As we reported (14) that ESW treatment, especially when combined with specific osteogenic 299 medium, elicited the differentiation of hASCs towards osteoblast-like cells, we assessed whether the 300 combined treatment could lead to the osteogenic differentiation of hASCs. As reported in Figure 7 , 301 the combined treatment with tenogenic medium and ESW had no effect on bone morphogenetic and some Authors reported that ASCs work better than bone marrow stem cells in in vivo tendon 318 injury models (21). Moreover, it has been described that ASC source can be biochemically induced 319 towards tenogenic commitment, validating its potential for tendon regeneration strategies (22).
Effects on osteogenic differentiation
320
Accordingly, in our in vitro model, tenogenic medium increased the expression of specific tendon 321 genes and determined collagen and fibronectin deposition.
322
Here we demonstrate that mechanical stimulation with ESW enhances the biochemical effects of a 323 containing-growth factor specific medium to drive hASCs towards a tenoblast-like phenotype. Our Force and scleraxis synergistically promote the commitment of human ES cells derived 
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